Positive Results in CelGro Nerve Repair Study
Filed with ASX · · 3 pages · English
● New clinical data 24-months after treatment shows nerve repair withCelGro® resulted in long term, predictable and consistent restoration of arm and hand function ● All quadriplegic patients regained voluntary movement of impaired or paralysed upper limbs within 12 months ● Patient enrolment is now completeinvolving repair of 35 nerves (19 patients) ● Progressing regulatory program in the US Pert
Story so far
Earlier from Orthocell
- CelGro Bone Regeneration in Dental & Orthopedic Applications
- CelGro Nerve Repair AUS Regulatory Application Submitted
- Orthocells Ortho-ATI Shows 87.5% Success Rate
- CelGro US 510(k) Submission Completed
- Successful CelGro US Bone Repair Study
Later from Orthocell
- CelGro Completes Pivotal Step in TGA Approval Process
- CelGro Receives Australian Market Approval
- Orthocell Receives First US CelGro Product Approval
- Orthocell Receives US Market Clearance
- Orthocell Receives A$2.3m R&D Tax Incentive Refund
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell